Pathology of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is a significant complication of obesity and is recognized as the hepatic manifestation of the metabolic syndrome. The process occurs in adults and children and is characterized by the presence of increased amounts of fat in the liver (steatosis). With inflammation, cell death and scarring (fibrosis), the process may result in end-stage liver disease, or be a precursor for hepatocellular carcinoma. Excess hepatic fat is now recognized as an independent marker for increased cardiovascular risk. Even though imaging studies and laboratory-based tests are accurate at detecting significant steatosis and/or advanced fibrosis, respectively, the diagnosis and characterization of NAFLD ultimately depend on histopathologic evaluation, as the parenchymal alterations that comprise the spectrum of injury in NAFLD include patterns as well as specific lesions. Histologic findings in children may differ from those in adults. In this Review, the histologic features that are diagnostic and discriminatory between steatosis and steatohepatitis, the significance of the distinction between steatosis and steatohepatitis, the types and locations of fibrosis, and the histologic variances between adult and pediatric NAFLD are discussed. Clinical advantages as well as potential drawbacks of liver biopsy are presented. Current pathophysiologic concepts relevant to histologic findings are discussed.

[1]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[2]  P. Socha,et al.  Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. , 2007, Roczniki Panstwowego Zakladu Higieny.

[3]  J. Layden-Almer,et al.  The Histologic Spectrum of Liver Disease in African-American, Non-Hispanic White, and Hispanic Obesity Surgery Patients , 2009, The American Journal of Gastroenterology.

[4]  Z. Younossi,et al.  Nonalcoholic fatty liver disease in patients with type 2 diabetes. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  M. Manos,et al.  Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.

[6]  B. Neuschwander‐Tetri,et al.  Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. , 2008, Archives of internal medicine.

[7]  W. Rosenberg,et al.  Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. , 2009, Gastroenterology.

[8]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[9]  Steven P. Larson,et al.  Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[10]  M. V. Van Natta,et al.  Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. , 2008, Gastroenterology.

[11]  P. Schirmacher,et al.  Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis , 2008 .

[12]  J. Ludwig,et al.  Two cases from the spectrum of nonalcoholic steatohepatitis. , 1995, Journal of clinical gastroenterology.

[13]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[14]  G. Dore,et al.  Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. , 2010, Gastroenterology.

[15]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[16]  A. McCullough,et al.  Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. , 2009, Clinics in liver disease.

[17]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[18]  P. D. James,et al.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.

[19]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[20]  A. Sanyal,et al.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  E. Vittinghoff,et al.  A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients , 2008, Hepatology.

[22]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[23]  A. McCullough,et al.  Update on nonalcoholic fatty liver disease. , 2002, Journal of clinical gastroenterology.

[24]  P. Giral,et al.  Liver fibrosis in overweight patients. , 2000, Gastroenterology.

[25]  L. Ferrell,et al.  158 Histologic correlation of paired right lobe and left lobe liver biopsies in morbidly obese individuals with suspected non alcoholic fatty liver disease , 2003 .

[26]  H. Conjeevaram,et al.  Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD , 2006, The American Journal of Gastroenterology.

[27]  R. Stravitz,et al.  Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome , 2003, American Journal of Gastroenterology.

[28]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[29]  J. Lefkowitch,et al.  Kupffer Cell Aggregation and Perivenular Distribution in Steatohepatitis , 2002, Modern Pathology.

[30]  J. Rotter,et al.  Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort , 2009, Obesity.

[31]  G. Leandro,et al.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.

[32]  S. Caldwell,et al.  Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.

[33]  V. Paradis,et al.  Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.

[34]  H. Cortez‐Pinto,et al.  Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients , 2004, The American Journal of Gastroenterology.

[35]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[36]  N. Kawada,et al.  Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. , 2009, Journal of atherosclerosis and thrombosis.

[37]  F. Yao Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes , 2008 .

[38]  S. Grundy,et al.  Ethnic differences in hepatic steatosis: An insulin resistance paradox? , 2009, Hepatology.

[39]  Kurt Zatloukal,et al.  Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. , 2008, Journal of Hepatology.

[40]  J. Goldblum,et al.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[41]  G. Tarantino,et al.  Silent non-alcoholic fatty liver disease-a clinical-histological study. , 2004, Journal of hepatology.

[42]  F. Ghishan,et al.  Nonalcoholic fatty liver disease in children: a single center experience. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[44]  Z. Younossi,et al.  Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  Paul Calès,et al.  Sources of variability in histological scoring of chronic viral hepatitis , 2005, Hepatology.

[46]  W. Kim,et al.  Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease , 2008, Hepatology.

[47]  B. S. Mohammed,et al.  Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.

[48]  J. Disario Comprehensive clinical hepatology , 2002, American Journal of Gastroenterology.

[49]  E. Brunt Alcoholic and nonalcoholic steatohepatitis. , 2002, Clinics in liver disease.

[50]  Z. Younossi,et al.  The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis. , 2000, Cleveland Clinic journal of medicine.

[51]  L. Krugner-Higby,et al.  573 The ballooned hepatocyte in NAFLD: Degenerative or adaptive? , 2004 .

[52]  P. Bejarano Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD—Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network , 2010 .

[53]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[54]  J. Benson,et al.  The natural history of non-alcoholic fatty liver disease , 2006 .

[55]  Chunhong Bai,et al.  Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[56]  H. Tilg,et al.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. , 2007, Gastroenterology.

[57]  C. McClain,et al.  Nutrition and nonalcoholic fatty liver disease in children , 2008, Current gastroenterology reports.

[58]  D. Nelson,et al.  Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[59]  J. Carvalheira,et al.  The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory , 2009, Obesity surgery.

[60]  F. Magkos,et al.  Methods for assessing intrahepatic fat content and steatosis , 2009, Current opinion in clinical nutrition and metabolic care.

[61]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[62]  B. Neuschwander‐Tetri,et al.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease , 2008, Gut.

[63]  T. Saibara,et al.  [Nonalcoholic steatohepatitis (NASH)]. , 2002, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[64]  D. Kershenobich,et al.  Hepatic Fibrosis , 1955, Gastroenterology.

[65]  A. Feldstein,et al.  Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.

[66]  M. Rinella,et al.  Non-alcoholic fatty liver disease: is bariatric surgery the answer? , 2009, Clinics in liver disease.

[67]  F. Marra,et al.  Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis , 2008, Hepatology.

[68]  D. Kleiner,et al.  Nonalcoholic Steatohepatitis (NASH) , 2010 .

[69]  M. Czaja,et al.  Autophagy regulates lipid metabolism , 2009, Nature.

[70]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[71]  L. N. Valenti,et al.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? , 2009, Seminars in Immunopathology.

[72]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[73]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[74]  P. Thuluvath,et al.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.

[75]  F. Marra,et al.  Adipokines in liver diseases , 2009, Hepatology.

[76]  G. Chejfec,et al.  Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? , 2008, Archives of pathology & laboratory medicine.

[77]  A. Lonardo,et al.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver , 2004, Hepatology.

[78]  Sang-hun Park Expanding the Natural History of Nonalcoholic Steatohepatitis: from Cryptogenic Cirrhosis to Hepatocellular Carcinoma , 2003 .

[79]  S. Caldwell,et al.  Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. , 2000, The American journal of medicine.

[80]  G. Gores,et al.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.

[81]  S. Auerbach,et al.  Impact of ethnicity , 1985 .

[82]  J. Lavine,et al.  Advances in pediatric nonalcoholic fatty liver disease. , 2011, Pediatric clinics of North America.

[83]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[84]  Beverley Balkau,et al.  Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population , 2009, Hepatology.

[85]  Steven P. Larson,et al.  Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[86]  B. Bacon,et al.  Comprehensive Clinical Hepatology , 2000 .

[87]  Roger J. R. Levesque,et al.  Obesity and Overweight , 2011 .

[88]  D. Huo,et al.  Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. , 2009, Journal of hepatology.

[89]  B. Neuschwander‐Tetri,et al.  Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease , 2003, Modern Pathology.

[90]  Tariq Hameed,et al.  Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[91]  S. Caldwell,et al.  Epidemiology and natural history of non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.

[92]  F. Marra,et al.  Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) , 2009 .

[93]  Manisha Talim,et al.  Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.

[94]  A. Feldstein,et al.  Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study , 2009, Hepatology.

[95]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[96]  T. Smyrk Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas , 2004 .

[97]  Parvez Hossain,et al.  Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.

[98]  L. N. Valenti,et al.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.

[99]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[100]  P. Bejarano Does Nonalcoholic Fatty Liver Disease Predispose Patients to Hepatocellular Carcinoma in the Absence of Cirrhosis , 2010 .

[101]  M. Sherman Hepatocellular carcinoma: epidemiology, risk factors, and screening. , 2005, Seminars in liver disease.

[102]  Michiie Sakamoto,et al.  Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[103]  G. Karaca,et al.  Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[104]  K. Koike,et al.  Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH , 2005, Journal of Gastroenterology.

[105]  P. Schirmacher,et al.  Differential pattern of lipid droplet‐associated proteins and de novo perilipin expression in hepatocyte steatogenesis , 2008, Hepatology.

[106]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[107]  E. Brunt,et al.  Nonalcoholic fatty liver disease: pathology and pathogenesis. , 2010, Annual review of pathology.

[108]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[109]  L. Adams,et al.  Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. , 2007, Clinics in liver disease.

[110]  M. Rugge,et al.  Liver biopsy sampling in chronic viral hepatitis. , 2004, Seminars in liver disease.

[111]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[112]  B. Neuschwander‐Tetri,et al.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network , 2009, Hepatology.

[113]  P. Giral,et al.  Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.

[114]  J. Patrie,et al.  Is NASH underdiagnosed among African Americans? , 2002, American Journal of Gastroenterology.

[115]  B. Neuschwander‐Tetri Non-alcoholic steatohepatitis , 2006 .

[116]  C. Nievergelt,et al.  Histopathology of pediatric nonalcoholic fatty liver disease , 2005, Hepatology.

[117]  B. Heniford,et al.  Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[118]  J. Browning New imaging techniques for non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.

[119]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[120]  S. Giday,et al.  Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients. , 2006, Journal of the National Medical Association.

[121]  J. Schwimmer,et al.  Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. , 2009, Seminars in pediatric surgery.

[122]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[123]  J. Schwimmer,et al.  Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease , 2008, Circulation.

[124]  J. Goldblum,et al.  Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas , 2003 .

[125]  R. Shprintzen,et al.  What's in a name? , 1990, The Cleft palate journal.

[126]  P. Ciampalini,et al.  NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice , 2006, Hepatology.